To include your compound in the COVID-19 Resource Center, submit it here.

BL-8040: Phase I started

BioLineRx began a 2-part, Israeli Phase I trial of subcutaneous BL-8040 in up to 40 healthy male volunteers.

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE